Teva Pharmaceuticals USA, Inc Recall: Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only
Teva Pharmaceuticals USA, Inc Recall: Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva Pharmaceuticals USA, Inc; Product: Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North
| Recalling firm | Teva Pharmaceuticals USA, Inc |
|---|---|
| Product | Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, a) 100 Capsules, NDC 0093-4068-01, b) 1000 Capsules, NDC 0093-4068-10 |
| Reason for recall | CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit for the above specified lots. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Ongoing |
| Distribution | U.S. Nationwide |
| Recall initiated | 20251007 |
| Recall number | D-0105-2026 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →